US Stock MarketDetailed Quotes

OSTX OS Therapies

Watchlist
  • 4.260
  • +0.080+1.91%
Close Jan 3 16:00 ET
90.48MMarket Cap-12.17P/E (TTM)

About OS Therapies Company

OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.

Company Profile

SymbolOSTX
Company NameOS Therapies
Listing DateAug 1, 2024
Issue Price4.00
Founded2018
CEOMr. Paul A. Romness, M.P.H.
MarketAMEX
Employees4
Fiscal Year Ends12-31
Address15825 Shady Grove Road,Suite 135
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-410-297-7793

Company Executives

  • Name
  • Position
  • Salary
  • Paul A. Romness, M.P.H.
  • President, Chief Executive Officer and Director
  • 360.00K
  • Gerald E. Commissiong
  • Chief Business Officer
  • --
  • Christopher P. Acevedo
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Robert G. Petit, PhD
  • Chief Medical Officer and Chief Scientific Officer
  • 360.00K
  • John Ciccio
  • Independent Director
  • 40.00
  • Avril McKean Dieser, J.D.,M.A.
  • Independent Director
  • --
  • Olivier R. Jarry, M.B.A.,M.S.
  • Independent Director
  • --
  • Dr. Theodore F. Search, Pharm.D.,R.Ph.
  • Independent Director
  • 40.00
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.